HER2- mBC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
HER2- mBC
Jun 21, 2024, 11:16 |
Insight
Paolo Tarantino: Phase 1 trial of the MMAF-based, HER2-targeting ADC FS-1502 published in Nature Communications
Paolo Tarantino shared on X/Twitter: "Phase 1 trial of the MMAF-based, HER2-targeting ADC FS-1502 published…
Jun 7, 2024, 13:10 |
Opinion
Paolo Tarantino: Among the ASCO24 abstracts, particularly notable was the DB03 update
Erika Hamilton shared Paolo Tarantino's post on X, adding: , "Agree, I…
May 25, 2024, 08:53 |
Insight
Sergio Cifuentes: Key potential insights in immunotherapy of maintenance in women with high T-cell Clonality
Sergio Cifuentes, Student Fellow at National Autonomous University of Mexico, shared on X: "Maintenance Pembrolizumab…
All:
3
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube